Literature DB >> 10195256

HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.

C Bartholomew1, N Jack, J Edwards, W Charles, D Corbin, F R Cleghorn, W A Blattner.   

Abstract

OBJECTIVES: It has been shown that > 90% of mothers of HTLV-I-infected children were themselves carriers of HTLV-I. This study was designed to determine the HTLV-I serostatus of mothers of patients with adult T-cell leukemia (ATL) and HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and to assess the association of age of exposure and disease outcome. STUDY DESIGN/
METHODS: In a cross-sectional study of the HTLV-I serostatus of mothers of HTLV-I-seropositive patients with ATL and HAM/TSP, 36 living mothers of patients with ATL and 15 mothers of patients with TSP/HAM were traced and enrolled.
RESULTS: Five of the 15 (33%) mothers of patients with HAM/TSP and 35 of the 36 (97.2%) mothers of patients with ATL were HTLV-I-seropositive. All patients were breast-fed and none received blood transfusions.
CONCLUSION: This study confirms that infection with HTLV-I in early childhood can lead to ATL in later life, and that HAM/TSP can also result from early infection but more commonly results from infection acquired in adulthood. There are several reports of posttransfusion HAM/TSP, but ATL has not been reported following blood transfusion except in patients who were immunocompromised. Because the newborn infant is considered to be immunoincompetent, it seems that this is a necessary factor for the development of ATL after infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10195256

Source DB:  PubMed          Journal:  J Hum Virol        ISSN: 1090-9508


  16 in total

1.  Persistent risk of adult T-cell leukemia/lymphoma after neonatal HTLV-1 infection through exchange transfusion.

Authors:  Eric Oksenhendler; Jocelyn Turpin; Raphael Lhote; Olivier Cassar; Jean-Michel Cayuela; Claire Fieschi; Lionel Galicier; Veronique Meignin; Charles Bangham; Antoine Gessain
Journal:  Int J Hematol       Date:  2017-01-30       Impact factor: 2.490

2.  Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice.

Authors:  Prabal Banerjee; Adam Tripp; Michael D Lairmore; Lindsey Crawford; Michelle Sieburg; Juan Carlos Ramos; William Harrington; Mark A Beilke; Gerold Feuer
Journal:  Blood       Date:  2010-02-01       Impact factor: 22.113

3.  Immune activation induces immortalization of HTLV-1 LTR-Tax transgenic CD4+ T cells.

Authors:  Alison Y Swaims; Francesca Khani; Yingyu Zhang; Arthur I Roberts; Satish Devadas; Yufang Shi; Arnold B Rabson
Journal:  Blood       Date:  2010-07-15       Impact factor: 22.113

Review 4.  Tumour virus epidemiology.

Authors:  Ruth M Lunn; Gloria D Jahnke; Charles S Rabkin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

5.  Proviral loads and clonal expansion of HTLV-1-infected cells following vertical transmission: a 10-year follow-up of children in Jamaica.

Authors:  Kazumi Umeki; Michie Hisada; Elizabeth M Maloney; Barrie Hanchard; Akihiko Okayama
Journal:  Intervirology       Date:  2009-05-20       Impact factor: 1.763

Review 6.  HTLV-1 and innate immunity.

Authors:  Chloé Journo; Renaud Mahieux
Journal:  Viruses       Date:  2011-08-08       Impact factor: 5.048

7.  Seroprevalence and correlates of human T-cell lymphoma/leukemia virus type 1 antibodies among pregnant women at the University of Nigeria Teaching Hospital, Enugu, Nigeria.

Authors:  Augustine Ejike Okoye; Obike Godswill Ibegbulam; Robinson Chukwudi Onoh; Paul Olisaemeka Ezeonu; Ngozi I Ugwu; Lucky Osaheni Lawani; Chukwudi Simon Anigbo; Charles E Nonyelu
Journal:  Int J Womens Health       Date:  2014-09-18

Review 8.  Early-life exposures to infectious agents and later cancer development.

Authors:  Vidya Vedham; Mukesh Verma; Somdat Mahabir
Journal:  Cancer Med       Date:  2015-09-17       Impact factor: 4.452

9.  Adult T-Cell Leukemia/Lymphoma in a Caucasian Patient After Sexual Transmission of Human T-Cell Lymphotropic Virus Type 1.

Authors:  David Sibon; Olivier Cassar; Isabelle Duga; Chantal Brouzes; David Ghez; Christophe Pasquier; Claire Sibon; Alexandra Desrames; Franck Mortreux; Eric Wattel; Ali Bazarbachi; Antoine Gessain; Olivier Hermine
Journal:  Open Forum Infect Dis       Date:  2015-03-06       Impact factor: 3.835

10.  Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net).

Authors:  Ariella L G Coler-Reilly; Naoko Yagishita; Hiroko Suzuki; Tomoo Sato; Natsumi Araya; Eisuke Inoue; Ayako Takata; Yoshihisa Yamano
Journal:  Orphanet J Rare Dis       Date:  2016-05-25       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.